Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial
Titel:
Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial
Auteur:
Pal, Sumanta Kumar Albiges, Laurence Tomczak, Piotr Suárez, Cristina Voss, Martin H de Velasco, Guillermo Chahoud, Jad Mochalova, Anastasia Procopio, Giuseppe Mahammedi, Hakim Zengerling, Friedemann Kim, Chan Osawa, Takahiro Angel, Martín Gupta, Suyasha Khan, Omara Bergthold, Guillaume Liu, Bo Kalaitzidou, Melania Huseni, Mahrukh Scheffold, Christian Powles, Thomas Choueiri, Toni K